Please login to read the full article.
Scrip Regulatory Affairs
The comitology overhaul: what this means for EU marketing authorisations
01 June 2011
Rick Clayton
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU animal tissue device rules: stricter rules for notified bodies and authorities
- EU falsified meds directive published, but industry split over safety features
- European Commission outlines new patent court to rescue single patent talks - update
- Long-awaited EU medtech e-IFU regulation is published, application deferred for one year
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
